TABLE 3.
Immunosuppression and management
| Patient | Organ type | Time from transplant to infection (d) | Induction | CNI | Antimetabolite | Total daily dose (mg) | mTOR | Pred | Immuno changes |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DDRT | 124 | IL2rAb | FK | MMF | 1000 | EVR | Yes | None |
| 2 | LDT | 2516 | ATG | FK | MPA | 1440 | Yes | d/c MPA | |
| 3 | LDT | 3366 | ATG | FK | MPA | 1440 | No | d/c MPA | |
| 4 | LDT | 1346 | ATG | FK | MMF | 2000 | Yes | d/c MMF | |
| 5 | DDRT | 7447 | Unknown | FK | MMF | 1000 | Yes | d/c MMF, FK | |
| 6 | LDT | 5000 | Unknown | FK | MMF | 500 | No | d/c MMF, FK | |
| 7 | DDRT | 1247 | IL2rAb | FK | MMF | 1000 | Yes | d/c MMF | |
| 8 | unknown | 6290 | Unknown | FK | MMF | 1500 | Yes | d/c MMF | |
| 9 | LDT | 3127 | IL2rAb | N/a | N/a | N/a | SRL | Yes | d/c SRL |
| 10 | DDRT | 1178 | Unknown | FK | MMF | 1000 | No | d/c MMF |
Abbreviations: ATG, antithymocyte globulin; CNI, calcineurin inhibitor; d/c, discontinue; DDRT, deceased donor renal transplant; EVR, everolimus; FK, tacrolimus; IL2rAb, IL2 receptor antibody; LDT, living donor renal transplant; MMF, mycophenolate mofetil; MPA, mycophenolic acid; mTOR, mammalian target of rapamycin; Pred, prednisone; SRL, sirolimus.